Latest Breaking News On - Sasha damouni ellis - Page 1 : comparemela.com

Vir Biotechnology, Inc (NASDAQ:VIR) Q1 2024 Earnings Call Transcript

Operator: Hello. Welcome to Vir Biotechnology’s First Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.

United statesDamouni ellisGena wangSasha damouni ellisAlec stranahanPhil nadeauNorbert bischofbergerPaul choiTsang leeCarrie huangRobert perezExchange commissionCorporate affairs officerWorld health organization global hepatitisWorld health organizationGoldman sachs

Vir Biotechnology, Inc (NASDAQ:VIR) Q4 2023 Earnings Call Transcript

Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript February 22, 2024 Vir Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.86, expectations were $-1.14. Vir Biotechnology, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello. Welcome to Vir […]

Sasha damouni ellisFastest growing industriesDamouni ellisGrowing industriesChief medical officerClinical development programsSasha damouni ellisMarianne de backerClinical programsDamouni ellis

Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024

Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sasha damouni ellisCarly scadutoCorporate affairsVir biotechnology incPress releasesVir biotechnologyMedia relationsVice presidentChief corporate affairs officer

Vir Biotechnology to Present Late-Breaking Data from Its Ongoing Phase 2 Chronic Hepatitis B and Delta Trials at AASLD s The Liver Meeting® 2023

Vir Biotechnology to Present Late-Breaking Data from Its Ongoing Phase 2 Chronic Hepatitis B and Delta Trials at AASLD s The Liver Meeting® 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesNew zealandCarly scadutoEdward ganeSasha damouni ellisTarik asselahUniversity of aucklandUniversity of parisCorporate affairsAlnylam pharmaceuticals incVir biotechnology incExchange commissionAmerican associationLiver diseasesLiver meeting

Vir Biotechnology, Inc (NASDAQ:VIR) Q3 2023 Earnings Call Transcript

Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2023 Earnings Call Transcript November 2, 2023 Vir Biotechnology, Inc. misses on earnings expectations. Reported EPS is $-1.22 EPS, expectations were $-1.21. Operator: Hello, and welcome to Vir Biotechnology’s Third Quarter 2023 Financial Results and Business Update Call. As a reminder, this conference call is being recorded. At this time, […]

United statesSasha damouni ellisJennifer towneChief scientificChief financial officerDamouni ellisGoldman sachsMonoclonal antibodyMonoclonal antibodySasha damouni ellisHepatitis deltaChief medical officerMarianne de backerInterferon alfaJung leeDamouni ellis